• Optimally tolerated dose of lapatinib in combinationwith docetaxel plus trastuzumab in first-line treatmentof HER2-positive metastatic breast cancer

    Simple item page

    Files

    Original bundle

    Now showing 1 - 1 of 1
    Thumbnail Image
    Name:
    Ann Oncol-2013-Crown-2005-11.pdf
    Size:
    147.88 KB
    Format:
    Adobe Portable Document Format
    Description:
    Download

    License bundle

    Now showing 1 - 1 of 1
    Thumbnail Image
    Name:
    license.txt
    Size:
    3.42 KB
    Format:
    Item-specific license agreed upon to submission
    Description:
    Download

    Collections

    Clinical Medicine (Scholarly Publications)
    RSS Feeds